Page last updated: 2024-10-27

gemfibrozil and Cardiotoxicity

gemfibrozil has been researched along with Cardiotoxicity in 1 studies

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
"Gemfibrozil (GEM) is a lipid-lowering drug with a number of biological properties such as anti-inflammatory and antioxidant activities."5.51Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. ( Aminzadeh, A; Fatemi, I; Goudarzi, M; Haybar, H; Kalantar, M; Khodayar, MJ; Mehrzadi, S, 2019)
"Gemfibrozil (GEM) is a lipid-lowering drug with a number of biological properties such as anti-inflammatory and antioxidant activities."1.51Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. ( Aminzadeh, A; Fatemi, I; Goudarzi, M; Haybar, H; Kalantar, M; Khodayar, MJ; Mehrzadi, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haybar, H1
Goudarzi, M1
Mehrzadi, S1
Aminzadeh, A1
Khodayar, MJ1
Kalantar, M1
Fatemi, I1

Other Studies

1 other study available for gemfibrozil and Cardiotoxicity

ArticleYear
Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Doxorubicin; Gemfibrozil; Hypolipidemic Agents

2019